Nestorone

CAS No. 7759-35-5

Nestorone( Elcometrine | Nestorone | ST-1435 | ST1435 )

Catalog No. M15930 CAS No. 7759-35-5

Nestoron2 (ST1435, Elcometrine) is a 19-norprogesterone derivative and steroidal progestin which is used as a hormonal contraceptive, a high-affinity agonist of the progesterone receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 51 In Stock
25MG 106 In Stock
50MG 203 In Stock
100MG 329 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nestorone
  • Note
    Research use only, not for human use.
  • Brief Description
    Nestoron2 (ST1435, Elcometrine) is a 19-norprogesterone derivative and steroidal progestin which is used as a hormonal contraceptive, a high-affinity agonist of the progesterone receptor.
  • Description
    Nestoron2 (ST1435, Elcometrine) is a 19-norprogesterone derivative and steroidal progestin which is used as a hormonal contraceptive, a high-affinity agonist of the progesterone receptor.Other Indication Discontinued(In Vivo):Nestoron (400 μCi 3H Nestoron/kg BW; subcutaneous injection; female Sprague-Dawley rats) treatment results in the Cmax in the blood and plasma are 58.1 and 95.5 ng equiv. 3H Nestoron/g, with t1/2 of 15.6 hours. Approximately, 81.4% and 7.62% of the administered dose is excreted via feces and urine, respectively.
  • In Vitro
    ——
  • In Vivo
    Nestoron (400 μCi 3H Nestoron/kg BW; subcutaneous injection; female Sprague-Dawley rats) treatment results in the Cmax in the blood and plasma are 58.1 and 95.5 ng equiv. 3H Nestoron/g, with t1/2 of 15.6 hours. Approximately, 81.4% and 7.62% of the administered dose is excreted via feces and urine, respectively. Animal Model:27 adult, female, Sprague-Dawley rats (200-225 g; age: 8 weeks)Dosage:400 μCi 3H Nestorone/kg BWAdministration:Subcutaneous injection (Pharmacokinetic study)Result:The mean peak concentrations of radioactivity (Cmax) in the blood and plasma were 58.1 and 95.5 ng equiv./g, with t1/2 of 15.6 hours. Approximately, 81.4% and 7.62% of the administered dose was excreted via feces and urine, respectively.
  • Synonyms
    Elcometrine | Nestorone | ST-1435 | ST1435
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    PR
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    7759-35-5
  • Formula Weight
    370.4819
  • Molecular Formula
    C23H30O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC([C@@]1(OC(C)=O)C(C[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4([H])[C@@]3([H])CC[C@]12C)=O)=C)=O
  • Chemical Name
    19-Norpregn-4-ene-3,20-dione, 17-(acetyloxy)-16-methylene-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. L?hteenm?ki P, et al. Contraception. 1981 Jan;23(1):63-75. 2. Suhonen S, et al. Fertil Steril. 1992 Jun;57(6):1211-5. 3. Coutinho EM, et al. Contraception. 1999 Feb;59(2):115-22.
molnova catalog
related products
  • Terutroban

    Terutroban (S-18886) is a potent, selective antagonist of the thromboxane receptor (Prostanoid TP receptor) that blocks thromboxane induced platelet aggregation and vasoconstriction.

  • MF-766

    MF-766 is a highly potent, selective and orally active EP4 antagonist with a Ki of 0.23 nM. It behaves as a full antagonist with an IC50 of 1.4 nM (shifted to 1.8 nM in the presence of 10% HS) in the functional assay. It can be used for cancer and inflammation diseases research.

  • Evatanepag

    Evatanepag is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.